Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
- 12 October 2004
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 68 (12), 2359-2366
- https://doi.org/10.1016/j.bcp.2004.08.021
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma: Implications for the Design of Therapeutic Trials in Patients With Advanced, Symptomatic Kaposi's SarcomaJournal of Clinical Oncology, 2004
- Prevention of Increasing Rates of Treatment Failure by Combining Sulfadoxine‐Pyrimethamine with Artesunate or Amodiaquine for the Sequential Treatment of MalariaThe Journal of Infectious Diseases, 2003
- Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitroPharmacological Research, 2003
- Treatment of Uncomplicated Multidrug‐Resistant Falciparum Malaria with Artesunate‐Atovaquone‐ProguanilClinical Infectious Diseases, 2002
- ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agentsThe FASEB Journal, 2002
- Mucosal Kaposiʼs sarcoma following protease inhibitor therapy in an HIV-infected patientAIDS, 1997
- CHEMOTHERAPY FOR AIDS‐RELATED AND ENDEMIC AFRICAN KAPOSI'S SARCOMA IN SOUTHERN AFRICAInternational Journal of Dermatology, 1995
- Angiogenic potential in vivo by Kaposiʼs sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2AIDS, 1994
- Matrigel promotes retinoblastoma cell growth in vitro and in vivoInternational Journal of Cancer, 1992
- Angiogenic Properties of Kaposi's Sarcoma-Derived Cells After Long-Term Culture in VitroScience, 1988